We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+6.64%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$493M
AUM Growth
+$24M
Cap. Flow
+$24.3M
Cap. Flow %
4.93%
Top 10 Hldgs %
73.64%
Holding
90
New
10
Increased
4
Reduced
3
Closed
7

Top Buys

Rank Stock Value
1
FNA
Paragon 28, Inc.
FNA
+$31.7M
2
INSM icon
Insmed
INSM
+$5.68M
3
ASH icon
Ashland
ASH
+$3.75M
4
DFLI icon
Dragonfly Energy
DFLI
+$2.48M
5
DD icon
DuPont de Nemours
DD
+$2.48M

Top Sells

Rank Stock Value
1
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$16.4M
2
THO icon
Thor Industries
THO
+$12.4M
3
BRIV
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
+$2.29M
4
FNCH
Finch Therapeutics Group, Inc. Common Stock
FNCH
+$267K
5
ISPC icon
iSpecimen
ISPC
+$88.2K

Sector Composition

Rank Sector Weight
1 Healthcare 24.15%
2 Consumer Discretionary 18.86%
3 Miscellaneous 17.38%
4 Industrials 13.81%
5 Materials 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQRX
76
DELISTED
EQRx, Inc. Common Stock
EQRX
$9.3K ﹤0.01%
5,000
– –
FNCH
77
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$8.28K ﹤0.01%
971
-26,043
-96% -$267K
WBD icon
78
Warner Bros
WBD
$72.1B
$5.01K ﹤0.01%
399
– –
SLGCW
79
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$3.5K ﹤0.01%
14,020
– –
ASTR
80
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$2.87K ﹤0.01%
518
– –
AVNW icon
81
Aviat Networks
AVNW
$256M
$2.2K ﹤0.01%
66
– –
WGS icon
82
GeneDx Holdings
WGS
$2.57B
$1.81K ﹤0.01%
303
– –
FAZEW
83
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$1.73K ﹤0.01%
75,000
– –
ADEA icon
84
Adeia
ADEA
$2.84B
– –
-90
Closed -$797
ISPC icon
85
iSpecimen
ISPC
$3.88M
– –
-82
Closed -$88.2K
XPER icon
86
Xperi
XPER
$293M
– –
-34
Closed -$372
QTEKW
87
DELISTED
QualTek Services Inc. Warrant
QTEKW
– –
-3,750
Closed -$114
BRIVW
88
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
– –
-75,000
Closed -$4.97K
BRIV
89
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
– –
-225,000
Closed -$2.29M
CTIC
90
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-3,893,730
Closed -$16.4M
1 2 3
4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return

Bleichroeder LP's Q2 2023 Portfolio in Review

As of Q2 2023, Bleichroeder LP held 90 positions worth $493M, up 5.1% from $469M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Bleichroeder LP deployed $24.3M of net new capital in Q2 2023, opening 10 new positions and adding to 4 existing holdings. Its largest new stake was Paragon 28, Inc.: 1,763,339 shares worth $26.8M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.

On the sell side, the largest reduction was Thor Industries, an estimated $12.4M trimmed.

  • Bleichroeder LP's largest Q2 2023 buy was Paragon 28, Inc.: 1,763,339 shares worth $26.8M.
  • Bleichroeder LP added most to Insmed in Q2 2023, an estimated $5.68M increase.
  • Bleichroeder LP's biggest Q2 2023 reduction was Thor Industries, cutting an estimated $12.4M.
  • Bleichroeder LP fully exited CTI BioPharma Corp. (DE) Common Stock in Q2 2023, selling an estimated $16.4M.
  • Bleichroeder LP's ten largest holdings make up 74% of its $493M portfolio in Q2 2023.
  • Bleichroeder LP opened 10 new positions and closed 7 in Q2 2023.
  • Bleichroeder LP's portfolio value rose 5.1% quarter-over-quarter to $493M.

Based on Bleichroeder LP's 13F filing for Q2 2023, filed 14 Aug 2023.